(NewsDirect)
Emergent HealthCorp . (OTC: EMGE) , a curator, developer, and marketerof products in the Regenerative Health Space announced today announcedrevenues of $373,406 for the quarter ended December 31, 2022 ascompared to $185,471 for the quarter ended September 30, 2022, anincrease of over 100% and revenues of $574,613 for the Year EndedDecember 31, 2022 as compared to $119,567 for the year ended December31, 2021, an increase of over 380%. The financial statement canbe viewed in its entirety at: https://www.otcmarkets.com/otcapi/company/financial-report/367945/content.
Jim Morrison, formerL'Oréal President and Emigrant’s new full time CEO stated,“The company is now engaged with several large biologics companies,and we expect enormous growth over the second and thirdquarter.”
Emergent projects to continue increasing its revenues quarterto quarter as it expands its business internally and externally byacquisition.
Recent Developments:
On February 23, 2023, announced that it anticipatesclosing the acquisition to acquire Nanosthetic Cosmetic Labs(“Nanosthetic”) shortly. Nanosthetic, of Fort Lauderdale Florida,holds proprietary intellectual property that has been developed overthe past ten years. The press release can be viewed in its entirety here .
On February 21, 2023,Emergent on behalf of its subsidiary, Evolutionary Biologics, Inc.,announced that it has executed a Letter of Intent to acquire aprivately held company in the regenerative medical field. The companyis profitable and does $5.4 Million in current revenues and projects atotal of $9 Million in revenues for 2023. The press release can beviewed in its entirety here .
The global biologicsmarket size was valued at US $366.43 billion in 2021and it is expected to hit over US$ 719.84 billion by 2030 with anoteworthy CAGR of 7.8% from 2022 to 2030. A biologic medication is aproduct that is made from live organisms and contains living organismcomponents. Examples of biologics are Recombinant protein, tissues,allergens, genes, cells, blood components, blood, and vaccinations areall examples of biologics. Examples of what can be treated are Anemia,hemophilia, chronic migraine, hepatitis B, rheumatoid arthritis,inflammatory bowel disease, and other disorders and infections aretreated with biologics. Our focus is on aesthetics cosmetics andmen’s and women’s health, but also wound care and tissueregeneration. Various government efforts, higher share of biologics inthe market, and rising use of biopharmaceuticals over chemicallyproduced molecules, and many other factors are driving the biologicsmarket expansion in the forecast period.
ABOUT EMERGENTHEALTH CORPORATION
Emergent curates, develops and sells products in theRegenerative Health Space. Its products comprise of ingestibles aswell as topicals for the whole family. The company distributes itsproducts online and through Content Based Shopping using Influencersto position products in their produced content throughout the UnitedStates and Internationally. Its subsidiaries; PharmaZu , is a pureplay, e-commerce products and service provider focused on the PetCommunity, Pet Pharmacy and Pet Wellness using Influencers and theircontent, including the pet pharmacy, vet telehealth and pet wellnessbusinesses; Regen BioWellness, is a distributor of various products inthe plant-based and regenerative medical fields. EvolutionaryBiologics , is a new kind of biologics company founded for aclear purpose: bring cutting edge regenerative products to the medicalcommunity. Emergent does not claim any of its products are approved bythe FDA to diagnose, treat, cure or prevent any disease. For moreinformation, please visit Emergent's Website andSocial Media on .
Before usingany products, you should always consult with your Veterinarian and/orFamily Doctor.
SAFE HARBOR STATEMENT
This press release contains forward-lookingstatements that can be identified by terminology such as“believes,” “expects,” “potential,” “plans,”“suggests,” “may,” “should,” “could,” “intends,”or similar expressions. Many forward-looking statements involve knownand unknown risks, uncertainties and other factors that may causeactual results to be materially different from any future resultsimplied by such statements. These factors include, but are not limitedto, our ability to continue to enhance our products and systems toaddress industry changes, our ability to expand our customer base andretain existing customers, our ability to effectively compete in ourmarket segment, the lack of public information on our company, ourability to raise sufficient capital to fund our business, operations,our ability to continue as a going concern, and a limited publicmarket for our common stock, among other risks. Many factors aredifficult to predict accurately and are generally beyond thecompany's control. Forward-looking statements speak only as to thedate they are made, and we do not undertake to update forward-lookingstatements to reflect circumstances or events that occur after thedate the forward-looking statements are made.
FOR MOREINFORMATION, PLEASE CONTACT:
Jim Morrison, CEO
Emergent HealthCorporation Website
i nfo@emergenthealthcompany.com
ContactDetails
Emergent Health Corp.
info@emergenthealthcompany.com
CompanyWebsite
https://emergenthealthcompany.com/
Copyright (c) 2023 TheNewswire - All rights reserved.